THE IDEAL CHOICE FOR
Cost-Effective High Throughput Syndromic Panels
Applied BioCode is an IVD manufacturer that designs, develops, and commercializes multiplex testing products.
View Our ProductsNEW PRODUCT – BioCode Fungal Panel
The BioCode® Fungal Panel Assay is a multiplexed deoxyribonucleic acid (DNA) amplification test intended for use with the BioCode® MDx-3000 Instrument.
For Research Use Only.
GPP Panel – 17 Targets
The FDA-cleared BioCode GI Panel tests for 17 of the most common pathogens associated with gastroenteritis
RPP Panel – 17 Targets
The BioCode Panel uses a syndromic approach to accurately detect and identify the pathogens most commonly associated with upper respiratory infections.
CoV-2 Flu Plus – 4 Targets
The BioCode CoV-2 Flu Plus Panel differentiates Flu A, Flu B , RSV, SARS-CoV-2 and potential co-infections during respiratory season.
SARS-CoV-2 Assay
The BioCode SARS-CoV-2 enables pooled testing of up to 5 individual upper respiratory specimens.
TESTIMONIALS
Hear From Our Clients
The adoption of the Applied BioCode platform, namely the BioCode® Gastrointestinal Pathogen Panel on the BioCode® MDx-3000 Instrument, has improved our lab workflow, where we receive accurate and fast test results while experiencing reduced invalid rates in our data. This in turn has enabled clinicians to manage their patients effectively.
ABOUT APPLIED BIOCODE
Transforming Your Lab Experience
Applied BioCode Inc. sets the standard for high throughput molecular diagnostics syndromic panel testing through its innovative advances in infectious disease testing.
Contact Us